News/ News/ Oncology/ Top stories Thousands to benefit as NHS funds Keytruda lung cancer combo Richard Staines cancer Merck & Co, lung cancer 0 Comment NICE has said MSD’s cancer immunotherapy, Keytruda, should receive interim funding on the NHS in certain patients with Share X Thousands to benefit as NHS funds Keytruda lung cancer combo https://pharmaphorum.com/news/thousands-to-benefit-as-nhs-funds-keytruda-lung-cancer-combo/
